S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
BREAKING: Tiny biotech successfully treats blindness (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
BREAKING: Tiny biotech successfully treats blindness (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
Nigeria's central bank chief arrested after being suspended by president
Famous Wall Street Crash System Flashes RED (Ad)
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
BREAKING: Tiny biotech successfully treats blindness (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
BREAKING: Tiny biotech successfully treats blindness (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
Nigeria's central bank chief arrested after being suspended by president
Famous Wall Street Crash System Flashes RED (Ad)
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
BREAKING: Tiny biotech successfully treats blindness (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
BREAKING: Tiny biotech successfully treats blindness (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
Nigeria's central bank chief arrested after being suspended by president
Famous Wall Street Crash System Flashes RED (Ad)
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
BREAKING: Tiny biotech successfully treats blindness (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
BREAKING: Tiny biotech successfully treats blindness (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
Nigeria's central bank chief arrested after being suspended by president
Famous Wall Street Crash System Flashes RED (Ad)
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive

Atrion (ATRI) Stock Forecast, Price & News

$561.80
+3.80 (+0.68%)
(As of 06/9/2023 ET)
Compare
Today's Range
$561.80
$561.80
50-Day Range
$500.00
$659.00
52-Week Range
$500.00
$705.74
Volume
1,869 shs
Average Volume
3,214 shs
Market Capitalization
$988.77 million
P/E Ratio
33.40
Dividend Yield
1.53%
Price Target
N/A

Atrion MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
2.55% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
1.55mentions of Atrion in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.63 out of 5 stars

Medical Sector

115th out of 987 stocks

Surgical & Medical Instruments Industry

10th out of 95 stocks


ATRI stock logo

About Atrion (NASDAQ:ATRI) Stock

Atrion Corp. engages in the manufacture and development of products for medical applications. It offers products for cardiovascular, fluid delivery, and ophthalmic. It also offers contract manufacturing and kitting services, and marine & aviation inflation components. The company was founded in 1944 and is headquartered in Allen, TX.

Receive ATRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atrion and its competitors with MarketBeat's FREE daily newsletter.

ATRI Stock News Headlines

Atrion (NASDAQ:ATRI) Shares Gap Up to $548.99
"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
ATRI - Atrion Corporation
Atrion (NASDAQ:ATRI) Sees Large Volume Increase
"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
10-Q: ATRION CORP
Atrion Reports First Quarter 2023 Results
Ophthalmic Diagnostic Devices Market Demand by 2031
Atrion (NASDAQ:ATRI) Shares Gap Down to $644.78
See More Headlines

ATRI Price History

ATRI Company Calendar

Last Earnings
11/01/2019
Ex-Dividend for 3/31 Dividend
3/14/2023
Dividend Payable
3/31/2023
Today
6/10/2023
Ex-Dividend for 6/30 Dividend
6/14/2023
Dividend Payable
6/30/2023
Next Earnings (Estimated)
8/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:ATRI
CUSIP
04990410
Employees
667
Year Founded
N/A

Profitability

Net Income
$35.01 million
Pretax Margin
19.53%

Debt

Sales & Book Value

Annual Sales
$183.51 million
Cash Flow
$27.73 per share
Book Value
$135.13 per share

Miscellaneous

Free Float
1,360,000
Market Cap
$988.77 million
Optionable
Not Optionable
Beta
0.48

Key Executives

  • David A. Battat
    President & Chief Executive Officer
  • Cindy Ferguson
    CFO, Secretary, Treasurer & Vice President













ATRI Stock - Frequently Asked Questions

How have ATRI shares performed in 2023?

Atrion's stock was trading at $559.45 at the beginning of 2023. Since then, ATRI shares have increased by 0.4% and is now trading at $561.80.
View the best growth stocks for 2023 here
.

When is Atrion's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023.
View our ATRI earnings forecast
.

How were Atrion's earnings last quarter?

Atrion Co. (NASDAQ:ATRI) issued its earnings results on Friday, November, 1st. The medical instruments supplier reported $5.15 earnings per share for the quarter. The medical instruments supplier had revenue of $38.88 million for the quarter. Atrion had a net margin of 17.01% and a trailing twelve-month return on equity of 12.36%.

How often does Atrion pay dividends? What is the dividend yield for Atrion?

Atrion announced a quarterly dividend on Tuesday, May 23rd. Investors of record on Thursday, June 15th will be given a dividend of $2.15 per share on Friday, June 30th. This represents a $8.60 dividend on an annualized basis and a yield of 1.53%. The ex-dividend date is Wednesday, June 14th.
Read our dividend analysis for ATRI
.

Is Atrion a good dividend stock?

Atrion (NASDAQ:ATRI) pays an annual dividend of $8.60 per share and currently has a dividend yield of 1.54%. The company has been increasing its dividend for 19 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 51.13%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for ATRI.

What is David A. Batta's approval rating as Atrion's CEO?

1 employees have rated Atrion Chief Executive Officer David A. Batta on Glassdoor.com. David A. Batta has an approval rating of 100% among the company's employees. This puts David A. Batta in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Atrion to a friend.

What other stocks do shareholders of Atrion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Atrion investors own include International Paper (IP), AT&T (T), WestRock (WRK), AbbVie (ABBV), Caterpillar (CAT), Eastman Chemical (EMN), Gilead Sciences (GILD), Altria Group (MO), Pfizer (PFE) and Philip Morris International (PM).

What is Atrion's stock symbol?

Atrion trades on the NASDAQ under the ticker symbol "ATRI."

Who are Atrion's major shareholders?

Atrion's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Kayne Anderson Rudnick Investment Management LLC (11.66%), Neuberger Berman Group LLC (10.88%), BlackRock Inc. (6.16%), Dimensional Fund Advisors LP (2.95%), State Street Corp (1.96%) and Boston Trust Walden Corp (1.81%). Insiders that own company stock include Emile A Battat and Jeffery Strickland.
View institutional ownership trends
.

How do I buy shares of Atrion?

Shares of ATRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Atrion's stock price today?

One share of ATRI stock can currently be purchased for approximately $561.80.

How much money does Atrion make?

Atrion (NASDAQ:ATRI) has a market capitalization of $988.77 million and generates $183.51 million in revenue each year. The medical instruments supplier earns $35.01 million in net income (profit) each year or $16.82 on an earnings per share basis.

How many employees does Atrion have?

The company employs 667 workers across the globe.

How can I contact Atrion?

Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The official website for the company is www.atrioncorp.com. The medical instruments supplier can be reached via phone at (972) 390-9800, via email at ir-info@atrioncorp.com, or via fax at 972-396-7581.

This page (NASDAQ:ATRI) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -